News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Jazz Pharmaceuticals plc (JAZZ) and Alkermes plc (ALKS) are Seen as Next Targets Amid Irish Deal Frenzy: Real M&A


8/6/2013 7:01:45 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

After two drug industry suitors already won lower tax rates through Irish acquisitions, investors are speculating Jazz Pharmaceuticals Plc (JAZZ) and Alkermes Plc (ALKS) may draw the next bids. Elan Corp. and Warner Chilcott Plc (WCRX), drug companies both domiciled in Ireland, this year found buyers motivated in part to cut their tax bill. The latest agreement, Perrigo Co. (PRGO)’s purchase of Elan announced July 29, helped drive shares of Jazz and Alkermes to a record and 12-year high, respectively, according to data compiled by Bloomberg.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg

comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES